Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS

Kidney International

Volumn 85, Issue 3, 2014, Pages 499-501

  Schlöndorff, Detlef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; SOLUBLE UROKINASE RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; CORTICOSTEROID;

CLINICAL EVALUATION; CREATININE URINE LEVEL; CRITICALLY ILL PATIENT; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; REVIEW; BLOOD; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; MALE; NEPHROTIC SYNDROME; PHYSIOLOGY; BLOOD LEVEL; CONGENITAL NEPHROTIC SYNDROME; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELISA KIT; GLOMERULOPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MEDICAL RESEARCH; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; RELIABILITY; REMISSION; URINARY EXCRETION;

FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; NEPHROTIC SYNDROME; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84895119023     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.549     Document Type: Note

References (18)

1. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011; 365: 2398-2411
2. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883
3. McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5: 2115-2121
4. Wei C, Mö ller CC, Altintas MM et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14: 55-63
5. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68: 635-641
6. Wei C, El Hindi S, Li J et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952-960
7. Wei C, Trachtman H, Li J et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23: 2051-2059
8. Slot O, Brü nner N, Locht H et al. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann Rheum Dis 1999; 58: 488-492
9. Yilmaz G, Kö ksal I, Karahan SC et al. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011; 44: 1227-1230
10. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 1999; 3: 15-32
11. Maas RJ, Wetzels JF, Deegens JK. Serumsoluble urokinase receptor concentration in primary FSGS. Kidney Int 2012; 81: 1043-1044
12. Maas RJ, Deegens JK, Wetzels JF. Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol 2013; 28: 1041-1048
13. Huang J, Liu G, Zhang YM et al. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 2013; 84: 366-372
14. Bock ME, Price HE, Gallon L et al. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 2013; 8: 1304-1311
15. Meijers B, Maas RJH, Sprangers B et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 2014; 85: 636-640
16. Wada T, Nangaku M, Maruyama S et al. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 2014; 85: 641-648
17. Sinha A, Bajpai J, Saini S et al. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 2014; 85: 649-658
18. Franco Palacios CR, Lieske JC, Wadei HM et al. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation 2013; 96: 394-399.